A review of pharmacogenetics of adverse drug reactions in elderly people.

about

Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial.Emerging Role of Precision Medicine in Cardiovascular Disease.Evaluation of buccal swabs for pharmacogenetics.

P2860

Q36267551-3083E335-75A9-46B0-970E-8002250D660C Q53748314-4FDC2DBE-0C40-48F9-8787-B67BE974B4BD Q55315387-062C91B1-6777-4CA2-B90E-DBB283C90C0F

P2860

A review of pharmacogenetics of adverse drug reactions in elderly people.

Item

http://www.wikidata.org/entity/Q38085220

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

A review of pharmacogenetics of adverse drug reactions in elderly people.

@en

type

Item

label

A review of pharmacogenetics of adverse drug reactions in elderly people.

@en

prefLabel

A review of pharmacogenetics of adverse drug reactions in elderly people.

@en

P1476

A review of pharmacogenetics of adverse drug reactions in elderly people.

@en

P2093

Andrea Corsonello

http://www.w3.org/2001/XMLSchema#string

Maurizio Cardelli

http://www.w3.org/2001/XMLSchema#string

Mauro Provinciali

http://www.w3.org/2001/XMLSchema#string

P2860

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

Medical genetics: a marker for Stevens-Johnson syndrome

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

P2888

bf03319099

P304

3-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03319099

http://www.w3.org/2001/XMLSchema#string

P478

35 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Fabrizia Lattanzio

Francesca Marchegiani

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010975545

http://www.w3.org/2001/XMLSchema#string

P698

23446782

http://www.w3.org/2001/XMLSchema#string

A review of pharmacogenetics of adverse drug reactions in elderly people.

about

P2860

P2860

A review of pharmacogenetics of adverse drug reactions in elderly people.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698